RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a tre… Read more
RaySearch Laboratories AB (publ) (RSLBF) - Total Assets
Latest total assets as of September 2025: $1.94 Billion USD
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RSLBF) holds total assets worth $1.94 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RaySearch Laboratories AB (publ) - Total Assets Trend (2003–2024)
This chart illustrates how RaySearch Laboratories AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
RaySearch Laboratories AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
RaySearch Laboratories AB (publ)'s total assets of $1.94 Billion consist of 47.1% current assets and 52.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 22.1% |
| Accounts Receivable | $462.72 Million | 22.1% |
| Inventory | $10.62 Million | 0.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $548.17 Million | 26.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how RaySearch Laboratories AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RaySearch Laboratories AB (publ)'s current assets represent 47.1% of total assets in 2024, a decrease from 74.1% in 2003.
- Cash Position: Cash and equivalents constituted 22.1% of total assets in 2024, up from 20.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 18.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 26.2% of total assets.
RaySearch Laboratories AB (publ) Competitors by Total Assets
Key competitors of RaySearch Laboratories AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
RaySearch Laboratories AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - RaySearch Laboratories AB (publ) generates 0.57x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, RaySearch Laboratories AB (publ) generates $9.73 in net profit.
RaySearch Laboratories AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 1.30 | 1.35 |
| Quick Ratio | 1.55 | 1.27 | 1.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $338.10 Million | $ 206.82 Million | $ 149.15 Million |
RaySearch Laboratories AB (publ) - Advanced Valuation Insights
This section examines the relationship between RaySearch Laboratories AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.64 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 7.1% |
| Total Assets | $2.09 Billion |
| Market Capitalization | $634.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values RaySearch Laboratories AB (publ)'s assets below their book value (0.30 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: RaySearch Laboratories AB (publ)'s assets grew by 7.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for RaySearch Laboratories AB (publ) (2003–2024)
The table below shows the annual total assets of RaySearch Laboratories AB (publ) from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.09 Billion | +7.09% |
| 2023-12-31 | $1.95 Billion | +4.09% |
| 2022-12-31 | $1.88 Billion | +7.52% |
| 2021-12-31 | $1.74 Billion | +35.79% |
| 2020-12-31 | $1.28 Billion | +1.64% |
| 2019-12-31 | $1.26 Billion | +14.37% |
| 2018-12-31 | $1.11 Billion | +20.80% |
| 2017-12-31 | $915.06 Million | +27.58% |
| 2016-12-31 | $717.25 Million | +48.04% |
| 2015-12-31 | $484.49 Million | +24.31% |
| 2014-12-31 | $389.75 Million | +30.28% |
| 2013-12-31 | $299.16 Million | +2.09% |
| 2012-12-31 | $293.03 Million | +12.27% |
| 2011-12-31 | $261.00 Million | +1.98% |
| 2010-12-31 | $255.93 Million | +9.79% |
| 2009-12-31 | $233.10 Million | +23.93% |
| 2008-12-31 | $188.09 Million | +8.58% |
| 2007-12-31 | $173.23 Million | +18.43% |
| 2006-12-31 | $146.27 Million | +36.47% |
| 2005-12-31 | $107.18 Million | +135.99% |
| 2004-12-31 | $45.42 Million | +47.67% |
| 2003-12-31 | $30.76 Million | -- |